BALLERUP, Denmark I July 23, 2025 I LEO Pharma, a global leader in medical dermatology, announced today that the U.S. Food and Drug Administration (FDA) has ...

SINGAPORE - A dermatitis cream that contains two potent medicinal ingredients has been ordered off the shelves, said the ...

One in 10 people with atopic dermatitis, the most common type of eczema, have symptoms on their feet. These quick facts can help you manage it.

A woman who had a small rash now looks 'like a burns victim' - after she suffered an extreme reaction to a common cream. Francesca Tebbutt, 33, said her skin was ''constantly on fire'' because of ...

Topical steroids can sometimes lead to withdrawal when stopping. Learn how to reduce your chance of this happening and what to do if it does.

Arcutis’ ZORYVE® (roflumilast) Cream 0.15% Receives Strong Recommendation in American Academy of Dermatology Updated Guidelines for Adult Atopic Dermatitis ...

The American Academy of Dermatology (AAD) provided evidence-based recommendation for the use of ZORYVE® (roflumilast) cream 0.15% in adults with mild to moderate atopic dermatitis (AD ...

WILMINGTON, Del., June 20, 2025 -- (BUSINESS WIRE)--Incyte (Nasdaq: INCY) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug ...

Arcutis Biotherapeutics has announced promising results from its Phase 3 INTEGUMENT-OLE study concerning the investigational ZORYVE cream for treating atopic dermatitis (AD). The long-term study ...

Arcutis to Present New Long-Term Results of ZORYVE® (roflumilast) Cream at the 2025 Revolutionizing Atopic Dermatitis Conference Arcutis Biotherapeutics, Inc. - GlobeNewswire - Fri Jun 6, 7:00AM CDT ...

Contact dermatitis is a skin condition that a number of allergens or irritant substances may cause. A person with contact dermatitis may develop a rash.